Oflup O Tablet is a combination antibiotic formulation containing Ofloxacin 200 mg and Ornidazole 500 mg, indicated for the treatment of mixed bacterial and protozoal infections. Ofloxacin, a fluoroquinolone antibiotic, exerts bactericidal activity by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing DNA replication and transcription in susceptible organisms. Ornidazole, a nitroimidazole derivative, is effective against anaerobic bacteria and protozoa by disrupting DNA synthesis and causing cell death. This synergistic combination is particularly useful in managing infections involving both aerobic and anaerobic pathogens, such as gastrointestinal infections, genitourinary tract infections, respiratory tract infections, and certain skin and soft tissue infections. Oflup O Tablet is prescribed to treat conditions like amoebiasis, giardiasis, bacterial vaginosis, and mixed aerobic-anaerobic bacterial infections. The medication should be administered as directed by a healthcare professional, with dosage adjustments based on the severity of infection and patient-specific factors. Caution is advised in patients with a history of hypersensitivity to fluoroquinolones or nitroimidazoles, and it should be used with care in individuals with renal or hepatic impairment. Common adverse effects may include gastrointestinal disturbances, dizziness, and headache. Complete the full course of therapy to prevent resistance development.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.